BrightSpring Health price target raised to $42 from $38 at Mizuho

Mizuho raised the firm’s price target on BrightSpring Health (BTSG) to $42 from $38 and keeps an Outperform rating on the shares as part of its 2026 outlook for managed care and health facilities. The firm believes 2026 will be a “pivotal year” for managed care. The sector is at the end of a three-year negative underwriting cycle and margins should improve in commercial, Medicaid and Medicare over the next few years, the analyst tells investors in a research note. As a result, Mizuho is positive on managed care heading into 2026.